BioQ Pharma Inc

SAN FRANCISCO, CA · Biotech · Private

Infusible pharmaceutical formulations and delivery systems for specialty drugs

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · bioqpharma.com

Sector: Biotech
Headquarters: SAN FRANCISCO, CA
Latest Form D: $4.6M, Jan 2020
Total capital: $63.9M

Federal grants: None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised: $59.9M; 7 Form D · last Jan 2020; 82 months since last filing
Federal contracts: $4M; 1 award · Defense; Rank in Biotech#98 of 4373
Granted patents: 6; 3 pending · first 2017; Rank in peer group#245 of 1449

Capital timeline

Latest events

Jan 2020Private capital raisedForm D · SEC · 7th filing$4.6M
Aug 2017Private capital raisedForm D · SEC · 6th filing$6.3M
Oct 2016Private capital raisedForm D · SEC · 5th filing$15M
Dec 2015Private capital raisedForm D · SEC · 4th filing$12.2M
Nov 2014Private capital raisedForm D · SEC · 3rd filing$13.7M
Sep 2013Federal contractDefense · Igf::ct::igf$4M
Apr 2013Private capital raisedForm D · SEC · 2nd filing$8.1M
Nov 2010Offering registeredForm D · SEC · 1st filing$7M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1449 peers

Line = median

Biotech · Molecule

Granted patents#245 · top 17%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants

Joshua W. KrieselResearcherExecutive Officer, DirectorLinked by 1 patent
Christopher J. PortmanDirectorNamed in SEC Form D filings
Daniel J. TasseDirectorNamed in SEC Form D filings
Llew J. KeltnerDirectorNamed in SEC Form D filings
Mark J. EhlertDirectorNamed in SEC Form D filings
Norvall William Jasper, Jr.DirectorNamed in SEC Form D filings

Show all 8 people

Richard J. NesbitDirectorNamed in SEC Form D filings
Ron W. PauliExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 6 granted of 9

May 24, 2022GrantedVariable Rate Dispenser With Aseptic Spike Connector AssemblyUSPTOUS 11,338,082
Sep 22, 2020GrantedTamper Evident Closure AssemblyUSPTOUS 10,780,259
May 7, 2019GrantedTwo Bottle Enclosed Desktop DispenserUSPTOUS D,847,974

Show all 9 patent records

Variable Rate Dispenser With Aseptic Spike Connector AssemblyMay 24, 2022 · US 11,338,082Granted
Tamper Evident Closure AssemblySep 22, 2020 · US 10,780,259Granted
Two Bottle Enclosed Desktop DispenserMay 7, 2019 · US D,847,974Granted
Two Part Reusable DispenserApr 30, 2019 · US D,847,328Granted
Combined Dispenser And Removable Two Vial CartridgeApr 30, 2019 · US D,847,327Granted
Unified Drug Mixer And DispenserOct 3, 2017 · US 9,775,946Granted
Sterile Assembled Liquid Medicament Dosage Control And Delivery DeviceApplication PCTUS2015052879Pending
Unified Drug Mixer And DispenserApplication PCTUS2016033186Pending
Variable Rate Dispenser With Aseptic Spike Connector AssemblyApplication PCTUS2020049556Pending

ALAMAR BIOSCIENCES, INC.Similar federal contract value in Biotech · $4.1M in contracts
CAIRN BIOSCIENCES INCSimilar federal contract value in Biotech · $4M in contracts
CELDARA MEDICAL, LLCSimilar federal contract value in Biotech · $4M in contracts
ANTAGEN BIOSCIENCES INCSimilar federal contract value in Biotech · $3.7M in contracts
Proniras CorpSimilar federal contract value in Biotech · $3.7M in contracts
Helix, Inc.Similar federal contract value in Biotech · $3.6M in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.